Is SNPX or XYLD a better dividend investment in 2026?

SNPX currently yields 25.48% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: SNPX offers higher current income.

What is the dividend yield difference between SNPX and XYLD?

SNPX has a forward dividend yield of 25.48% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 14.50 percentage points.

Home › Compare › SNPX vs XYLD

SNPX vs XYLD: Dividend Comparison 2026

SNPX yields 25.48% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XYLD wins by $893.00 in total portfolio value· pulled ahead in Year 10

INVESTMENT

TIME HORIZON10 years

SNPX

● Live price

25.48%

Share price

$7.85

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.4K

Annual income

$3.08

Full SNPX calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — SNPX vs XYLD

📍 XYLD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SNPX	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SNPX + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SNPX pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNPX

Annual income on $10K today (after 15% tax)

$2,165.61/yr

After 10yr DRIP, annual income (after tax)

$2.62/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, XYLD beats the other by $2,733.55/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNPX + XYLD for your $10,000?

SNPX: 50%XYLD: 50%

100% XYLD50/50100% SNPX

Portfolio after 10yr

$24.8K

Annual income

$1,611.05/yr

Blended yield

6.49%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SNPX right now

SNPX

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-3.0

Piotroski

0/9

XYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNPX buys

XYLD buys

No recent congressional trades found for SNPX or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSNPXXYLD

Forward yield	25.48% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	0% ✓
Portfolio after 10y	$24.4K	$25.3K ✓
Annual income after 10y	$3.08	$3,219.02 ✓
Total dividends collected	$2.7K	$19.6K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: SNPX vs XYLD ($10,000, DRIP)

Year	SNPX Portfolio	SNPX Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1	$11,974	$1,273.89	$10,818	$1,098.39	+$1.2K → SNPX
2	$13,525	$712.77	$11,738	$1,222.51	+$1.8K → SNPX
3	$14,848	$376.21	$12,774	$1,364.64	+$2.1K → SNPX
4	$16,080	$193.00	$13,944	$1,527.86	+$2.1K → SNPX
5	$17,303	$97.67	$15,270	$1,715.87	+$2.0K → SNPX
6	$18,564	$49.11	$16,775	$1,933.09	+$1.8K → SNPX
7	$19,888	$24.62	$18,490	$2,184.87	+$1.4K → SNPX
8	$21,292	$12.33	$20,450	$2,477.63	+$842.00 → SNPX
9	$22,789	$6.17	$22,697	$2,819.19	+$92.00 → SNPX
10← crossover	$24,387	$3.08	$25,280	$3,219.02	$893.00 → XYLD

SNPX vs XYLD: Complete Analysis 2026

SNPX — Stock

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.

Full SNPX Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this SNPX vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNPX vs SCHD SNPX vs JEPI SNPX vs O SNPX vs KO SNPX vs MAIN SNPX vs QYLD SNPX vs JEPQ SNPX vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.